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.Introduction: Chronic mesenteric ischemia (CMI) is a challenging problem, with revascularization the mainstay of
treatment. Management of CMI is especially challenging in the patient with superior mesenteric artery (SMA)
and celiac artery (CA) occlusions.
Report: We report a case series of four patients with chronic mesenteric ischemia who were not candidates for
CA or SMA revascularization who were successfully treated with inferior mesenteric artery (IMA) angioplasty and
stent placement to improve collateral circulation and palliate symptoms.
Discussion: To our knowledge, this is the largest case series to date reporting the use of an IMA stent to improve
collateral circulation in patients with CMI.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd.
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Open access under CC BY-NC-ND licenseINTRODUCTION
Chronic mesenteric ischemia (CMI) is a challenging problem
with a signiﬁcant economic impact and a catastrophic
outcome if left untreated.1 This case series reports four
patients with chronic mesenteric ischemia who were not
candidates for CA or SMA revascularization but who were
successfully treated with inferior mesenteric artery (IMA)
angioplasty and stent placement to improve collateral cir-
culation and palliate symptoms.CASE SERIES
Patient number 1
A 77-year-old male with hypertension, type II diabetes,
ischemic cardiomyopathy, and tobacco abuse presented
with a three week history of severe postprandial abdominal
pain. A computed tomography (CT) scan revealed a high-
grade stenosis of the ﬁrst 3 cm of the superior mesen-
teric artery (SMA), which was also highly calciﬁed. The celiac
trunk was calciﬁed along its entire course but appeared to
be patent, without signiﬁcant stenosis (Fig. 1A). The inferior
mesenteric artery (IMA) had a tight stenosis at its origin but
was otherwise patent, with a well-developed Riolan arcade
(Fig. 1B). Because the entire length of the SMA was
diseased and heavily calciﬁed, and no stenosis could beof original article: http://dx.doi.org/10.1016/j.ejvs.2014.01.008
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celiac trunk was a target for intervention. As the Riolan
arcade was well developed, IMA stenting was chosen. An-
gioplasty was performed via a left brachial puncture and a
6  18 mm stent (Herculink, Boston, MA, USA) placed. Two
stenoses, one at the origin of the left colic and one at the
origin of the superior rectal artery, were also dilated by
balloon angioplasty (Fig. 1C). The postoperative course was
uneventful and the abdominal pain resolved completely. Six
months after the operation, the patient underwent a con-
trol angiogram that showed a patent stent without intra-
stent stenosis. One year after the procedure, a duplex
ultrasound and a CT scan both showed a patent stent and
the patient remains asymptomatic.Patient number 2
A 54-year-old male with ischemic cardiomyopathy, tobacco
abuse, and previous stroke presented with postprandial
abdominal pain and 40 pound weight loss over the previous
4 months. Esophagogastroduodenoscopy showed no iden-
tiﬁable abnormalities. CT scan showed a 4.5-cm segment of
thrombosed SMA, a short occlusion of the celiac trunk, and
a tight stenosis of the IMA consistent with chronic
mesenteric ischemia (Fig. 2A, B).
A 5  15 mm stent was placed (Herculink) via a percu-
taneous brachial approach. Control angiography showed
perfusion of the Riolan arcade and branches of the IMA
(Fig. 2C). Postoperatively, the abdominal pain resolved
completely. At 6-month follow-up he had recovered his
normal weight. A control angiogram and a duplex scan
showed no intrastent stenosis (Fig. 2D). Seven months later,
the stent was still patent but the patient presented with
Figure 1. Patient number 1 preoperative image, with a computed tomography angiogram revealing a high-grade stenosis of the ﬁrst 3-cm
of a heavily calciﬁed superior mesenteric artery and a widely patent celiac artery (A). The inferior mesenteric artery had a tight stenosis at
its origin but otherwise appeared patent, with a well-developed Riolan arcade (B). Completion angiogram shows stent in the inferior
mesenteric artery (C).
Figure 2. Patient number 2. A computed tomography scan showed a 4.5-cm segment of thrombosed superior mesenteric artery, and
stenosis of the celiac trunk, consistent with chronic mesenteric ischemia (A). At the end of the case, angiography showed perfusion of the
Riolan arcade and branches of the inferior mesenteric artery (B). Postoperative computed tomography scan and 6-month follow-up
angiogram showing patent stent in the inferior mesenteric artery (C, D).
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from the supra coeliac aorta to revascularize the celiac
trunk, SMA, and IMA was performed. The patient recovered
uneventfully.
Patient number 3
A 70-year-old male with hypertension, tobacco abuse, se-
vere alcoholism, and cirrhosis presented with worsening
abdominal pain for several weeks and 20 pound weight loss
in the previous 2 months. A CT scan showed short occlu-
sions of the celiac trunk and SMA, and a tight stenosis of
the IMA. The SMA and celiac trunk were highly calciﬁed and
deemed unsuitable for safe endovascular treatment. The
patient was turned down for open repair. A 6  20 mm IMA
stent (Formula Cook Medical, Bloomington, IN, USA) stent
was placed. At review 3 months after the procedure, the
patient was asymptomatic and had recovered his normal
weight. Six months after the procedure, a control angio-
gram showed an intrastent stenosis. Intrastent angioplasty
was performed. The patient remained asymptomatic 1 year
after the procedure, with a duplex scan and a CT scan
showing a widely patent IMA stent.
Patient number 4
This patient was a 48-year-old female with hypertension,
tobacco abuse, hyperlipidemia, pulmonary embolism, deep
vein thrombosis, factor II deﬁciency, activated protein C
resistance, HIV, and hepatitis C. The past medical history
included a saphenous vein aortomesenteric bypass for
chronic mesenteric ischemia. Six months after this opera-
tion, an angioplasty of the bypass was performed for
symptomatic stenosis, followed by stenting of the bypass 1
year later for continued symptoms. She presented 2 years
later with occlusion of the bypass and recurrent pain. At
this point she received a 6  20 mm IMA stent (Formula
Cook Medical, Bloomington, IN, USA) with good angio-
graphic result. Six months after the operation, she remained
asymptomatic, with no intrastent restenosis on duplex scan
and CT scan.
DISCUSSION
To our knowledge, this is the largest case series to date
reporting the use of an IMA stent to improve collateral
circulation in patients with CMI. This technique of IMA
stenting has also been corroborated by a German group
who reported technical success and excellent short term
results in three patients.2Surgical revascularization remains the gold standard for
CMI. Inﬂow may be from the supraceliac/descending
thoracic or ascending aorta (antegrade) or the infrarenal
aorta or common iliac artery (retrograde). Outﬂow is most
frequently to the CA and SMA, and rarely to the IMA. A
recent case series of 98 patients with CMI reported a 92% 5-
year symptom-free survival with two-vessel reconstruction
(celiac, SMA); IMA reconstruction added morbidity to the
surgery and was considered unnecessary.3 In spite of
excellent outcomes using surgical bypass, many patients
with CMI cannot tolerate an open procedure; therefore,
these patients become candidates for endovascular revas-
cularization.4 For these reasons, the preferred strategy is to
perform SMA and/or CA revascularization whenever
possible. IMA stenting rather than CA/SMA revasculariza-
tion is performed only in the setting of long or heavily
calciﬁed lesions of the SMA/CA.
The current surveillance plan includes duplex scan at 1
month, 3 months, and every 6 months, CT angiogram at 3
months and yearly thereafter, followed by angiogram at 6
months. We perform angiography in order to detect occult
intrastent stenosis not seen on the CT angiogram. Patients
are placed on double antiplatelet therapy for at least 6
months postoperatively.FUNDING
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